
Director, Late Stage Clinical Development
Posted Aug 26

Posted Aug 26
This is a fully remote position, open to applicants in United States.
• Develop and implement comprehensive strategies for Expanded Access Programs and late-stage studies within Definium’s portfolio.
• Direct the global strategy for Expanded Access Programs and late-stage development, ensuring alignment with asset lifecycle goals, patient access objectives, and regulatory standards.
• Collaborate with cross-functional teams to incorporate Expanded Access Program and late-stage clinical initiatives into the overall asset strategy.
• Oversee the development and execution of Expanded Access Programs, including protocol formulation, eligibility requirements, safety supervision, and operational implementation.
• Guarantee that Expanded Access Programs adhere to compliance, scalability, ethical standards, and regulatory guidelines.
• Provide consultation on benefit-risk assessments, safety monitoring, and ongoing evaluation of programs.
• Assist in the strategy for generating late-stage clinical evidence, focusing on real-world evidence, long-term safety, effectiveness, and treatment differentiation.
• Lead the design, planning, and execution of Phase 4 and investigator-initiated clinical evidence programs.
• Ensure that program designs meet regulatory commitments, payer requirements, and scientific needs.
• Collaborate on clinical content for regulatory submissions and engagements.
• Offer clinical insights for Investigator Brochures and clinical study reports.
• Work with Clinical Operations, Clinical Development, Data Management, Biostatistics, Pharmacovigilance, and Project Management to ensure high-quality execution.
• Maintain connections with investigators, advisors, and external experts.
• Provide clinical leadership within matrix teams.
• A doctoral degree is required (MD, PhD, PharmD, PsyD).
• 6-8+ years of clinical development experience within the pharmaceutical or biotechnology sectors.
• Proven experience in leading Expanded Access programs and late-stage, post-approval initiatives.
• Experience in selecting and managing third-party vendors to support operational aspects of Expanded Access and late-stage evidence programs.
• CNS clinical development experience in psychiatry is strongly preferred.
• Experience in budget management, including forecasting, tracking, and overseeing multiple programs.
• Familiarity with expanded access program requirements, clinical development, regulatory pathways, and lifecycle management.
• Demonstrated ability to translate strategy into execution within resource-constrained settings.
• Track record of successful cross-functional leadership and engagement with external stakeholders.
• Ability to operate with diplomacy, influence without authority, and establish credibility with senior leaders and external experts.
• Excellent verbal and written communication skills.
• Self-motivated, adaptable, and adept at balancing strategic thinking with hands-on contributions.
• Willingness to engage actively while maintaining a strategic viewpoint.
• Enthusiastic about innovation in clinical research and patient-centric access models.
• Thrives in a dynamic, fast-paced environment with high expectations of accountability.
• Acts as a role model for scientific excellence, integrity, and teamwork.
• 100% paid health benefits including Medical, Dental, and Vision coverage for you and your dependents.
• 401(k) program with company matching and vesting beginning after the first month post-start date.
• Flexible time off.
• Generous parental leave along with several enjoyable fringe benefits!
• Additional compensation, which may include bonuses and equity, could also be available.
Headway
Reinsurance Group of America, Incorporated
Regeneron
CommandLink
Get handpicked remote jobs straight to your inbox weekly.